Viridian Capital Advisors, established in 2014, is a premier corporate finance, M&A, advisory, and research firm specializing in the legal Cannabis/CBD and Psychedelics industries. With a focus on institutionalizing clients before capital or M&A activities, Viridian offers comprehensive services including building professional Boards of Directors, financial modeling, valuation analyses, and exit strategies. Through their New York City-based broker-dealer, Bradley Woods & Co. Ltd., Viridian raises capital and facilitates M&A transactions. Renowned for their industry-leading research and market intelligence, particularly through the Viridian Deal Tracker, which has analyzed over $60 billion in deals, Viridian is a trusted partner for companies, investors, lenders, buyers, and sellers in the cannabis and psychedelics sectors.